Victoza Lawyers of Onder Law

Victoza Pancreatic Cancer

Pancreas Problems Including Pancreatitis and Pancreatic Cancer Have Occurred After Using Victoza

Research shows that persons who take Victoza have a higher risk for developing pancreas problems. Victoza pancreas problems include acute pancreatitis and pancreatic cancer, both of which can be life-threatening. American consumers and medical professionals were not adequately warned of the risk of pancreatic cancer from Victoza. This page provides detailed information the the risk of pancreas problems from Victoza as well as who qualifies to file a claim against Novo Nordisk related to pancreatic cancer and acute pancreatitis from Victoza.

Victoza Diabetes Treatment

Victoza is an FDA-approved treatment for Type 2 diabetes. Injected once daily, Victoza lowers blood sugar levels in order to prevent diabetes complications such as blindness and kidney disease. However, because of the emphasis on stimulating the pancreas to produce insulin, many patients suffer from Victoza pancreas problems.

Patients who suffer from Typ1 2 diabetes lack hormones known as incretins. Incretins such as Glucagon-Like Peptide-1 (GLP-1) stimulate the natural production of insulin, which serves to balance glucose levels in the bloodstream. Victoza works by increasing GLP-1 receptor activity, causing the pancreas to release insulin.

Victoza Risks

From the time Victoza was first approved in January of 2010, federal regulators had concerns over its safety. Early clinical reviews indicated a risk for pancreas and thyroid problems including cancer. At the time of initial approval, the FDA required the adoption of a Risk Evaluation and Mitigation Strategy and continued safety studies. At this time, Victoza is not recommended as a "first-line" diabetes therapy due to "several safety concerns".

Victoza Acute Pancreatitis

Patients who take Victoza are 3.7 times more likely to develop pancreatitis than those not taking the drug. Acute pancreatitis from Victoza is a serious condition that can be life-threatening if not diagnosed and treated expeditiously.

Acute pancreatitis is characterized by sudden inflammation and swelling, causing the organ to lose its blood supply. Patients experience debilitating pain, and the condition’s rapid onset can quickly cause irreversible internal damage including tissue death, organ system failure, and even death. Symptoms of Victoza pancreatitis include abdominal pain and tenderness, fever, nausea, vomiting, sweating, clay-colored stools, bloating and indigestion, rapid heartbeat and breathing, and jaundice.

Drugmaker Hid Victoza Pancreas Problems

Pancreas problems are an expected side effect of incretin mimetics, but the risk for acute pancreatitis from Victoza is more significant than for other similar drugs. In fact, there are 11 comparable drugs used to treat Type 2 diabetes that have a lower risk for pancreas problems than Victoza. Yet Victoza is the most popular and best-selling drug in the class. Critics point to Novo Nordisk’s illegal marketing tactics which included downplaying the Victoza pancreatitis risk and paying kickbacks to physicians.

Victoza Pancreatic Cancer

Multiple studies have confirmed suspicions linking Victoza to pancreatic cancer. In February of 2013, result of a study were published in JAMA (The Journal of the American Medical Association) which found cancerous pancreas cells in many subjects. These Victoza pancreatic cancer findings prompted the 2013 FDA Victoza pancreatic cancer warning, three years after the drug was first approved in the United States. Alarmingly, while the Victoza warning label was updated to include new warning information, the term pancreatic cancer was not added to the Victoza drug label. We also know now that, according to a U.S. Department of Justice lawsuit, Novo Nordisk illegally promoted the drug to physicians, downplaying the Victoza cancer risk as false or unimportant.

In 2016, results of the LEADER clinical trial were released, confirming original Victoza pancreatic findings. The LEADER trial found that persons taking Victoza were three times as likely to develop pancreatic cancer as persons taking a placebo. Most patients who agreed to take the drug were unaware of the heightened risk of pancreatic cancer from Victoza when compared to other effective diabetes treatments.

Let Our Victoza Cancer Lawyers Help You

Our attorneys specialize in holding large corporations accountable when they've placed profits ahead of safety. Through settlements and winning verdicts, our attorneys have obtained millions for our clients. Let us help you today.

Victoza Lawsuits for Pancreas Problems

Filing a lawsuit will allow you to hold the pharmaceutical company accountable for damage it has caused you or a loved one, while also providing real compensation for your medical expenses, suffering and loss. Contact us today for a free consultation.

For more information, visit our Victoza Pancreas Lawsuit website.

Free Case Review


Onder Law holds the highest possible peer review rating from Martindale-Hubbell

Onder Law holds the highest possible peer review rating from Martindale-Hubbell

Million Dollar Advocates Forum

We have been recognized by the Million Dollar Advocates Foum for securing million dollar settlements on behalf of our clients. Fewer than 1% of all attorneys receive this recgonition.

Multi-Million Dollar Advocates Forum

We have been recognized by the Million Dollar Advocates Foum for securing multi-million dollar settlements on behalf of our clients. Fewer than 1% of all attorneys receive this recgonition.

Super Lawyers

The attorneys of Onder Law have been recognized as Super Lawyers

Multi-Million Dollar Advocates Forum

We have been nominated as one of the Best Attorneys in America - The Most Qualified Attorneys in Our Country by Rue Ratings

Member National Trial Lawyers Association

The attorneys of Onder Law are proud members of the National Trial Lawyers Association


Onder Law handles mass tort claims that are filed in federal courts nationwide. Attorneys at Onder Law are licensed only in Missouri, Illinois and Kansas; however our attorneys have handled cases nationwide* including in: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.

Attorneys at Onder Law have represented clients in federal multi-district litigation in the following cities*: Atlanta, GA, Austin, TX, Baltimore, MD, Birmingham, AL, Boston, MA, Buffalo, NY, Charlotte, NC, Chicago, IL, Cincinnati, OH, Cleveland, OH, Columbus, OH, Dallas, TX, Denver, CO, Detroit, MI, Fresno, CA, Hartford, CT, Honolulu, HI, Houston, TX, Indianapolis, IN, Jacksonville, FL, Kansas City, MO, Las Vegas, NV, Los Angeles, CA, Louisville, KY, Memphis, TN, Miami, FL, Milwaukee, WI, Minneapolis, MN, Nashville, TN, New Orleans, LA, New York, NY, Oklahoma City, OK, Orlando, FL, Philadelphia, PA, Phoenix, AZ, Pittsburgh, PA, Portland, OR, Providence, RI, Raleigh, NC, Richmond, VA, Riverside, CA, Rochester, NY, Sacramento, CA, Salt Lake City, UT, San Antonio, TX, San Diego, CA San Francisco, CA, San Jose, CA, Seattle, WA, St. Louis, MO, Tampa, FL, Tucson, AZ, Tulsa, OK, Virginia Beach, VA and Washington, DC.

* In order to represent clients in states where the attorneys are not licensed, they must be granted admission pro hac vice or associate with local counsel.